• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
BCOR Expression in Mullerian Adenosarcoma: A Potential Diagnostic Pitfall.BCOR 在 Müllerian 腺肉瘤中的表达:潜在的诊断陷阱。
Am J Surg Pathol. 2020 Jun;44(6):765-770. doi: 10.1097/PAS.0000000000001445.
2
Diagnostic Value of Combined BCOR, Cyclin D1, and CD10 in Differentiating Endometrial Stromal Sarcoma From Other Uterine Spindle Cell Lesions.BCOR、Cyclin D1 和 CD10 联合检测对鉴别子宫内膜间质肉瘤与其他子宫梭形细胞病变的诊断价值。
Appl Immunohistochem Mol Morphol. 2024 Aug 1;32(7):326-335. doi: 10.1097/PAI.0000000000001213. Epub 2024 Jul 4.
3
Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.未分化子宫肉瘤代表认识不足的高级子宫内膜间质肉瘤。
Am J Surg Pathol. 2019 May;43(5):662-669. doi: 10.1097/PAS.0000000000001215.
4
Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling.子宫腺肉瘤的鉴别诊断:通过全面癌症基因组分析鉴定 JAZF1-BCORL1 重排。
Diagn Pathol. 2023 Jan 13;18(1):5. doi: 10.1186/s13000-022-01279-4.
5
BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.BCOR 是一种强有力的诊断免疫组化标志物,可用于多种遗传学上不同的高级别子宫内膜间质肉瘤,包括具有变异形态的肿瘤。
Mod Pathol. 2017 Sep;30(9):1251-1261. doi: 10.1038/modpathol.2017.42. Epub 2017 Jun 16.
6
Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.具有 BCOR 内串联重复和变异 BCOR/BCORL1 重排的子宫内膜间质肉瘤类似于具有反复 CDK4 通路改变和 MDM2 扩增的高级别子宫内膜间质肉瘤。
Am J Surg Pathol. 2022 Aug 1;46(8):1142-1152. doi: 10.1097/PAS.0000000000001909. Epub 2022 May 3.
7
Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications.伴有BCOR重排的子宫内膜间质肉瘤存在MDM2基因扩增。
J Pathol Clin Res. 2020 Jul;6(3):178-184. doi: 10.1002/cjp2.165. Epub 2020 Apr 30.
8
[Clinicopathological study of BCOR rearrangement in high grade endometrial stromal sarcoma].[高级别子宫内膜间质肉瘤中BCOR重排的临床病理研究]
Zhonghua Bing Li Xue Za Zhi. 2019 Aug 8;48(8):604-609. doi: 10.3760/cma.j.issn.0529-5807.2019.08.004.
9
Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma.腺肉瘤和子宫内膜间质肉瘤中子宫内膜干/祖细胞(ES/PC)标志物的表达谱。
Cancer Treat Res Commun. 2021;27:100363. doi: 10.1016/j.ctarc.2021.100363. Epub 2021 Mar 31.
10
JAZF1, YWHAE and BCOR gene translocation in primary extrauterine low-grade and high-grade endometrial stromal sarcomas.原发性子宫外低级别和高级别子宫内膜间质肉瘤中 JAZF1、YWHAE 和 BCOR 基因易位。
Histopathology. 2022 Apr;80(5):809-819. doi: 10.1111/his.14608. Epub 2022 Feb 7.

引用本文的文献

1
Aberrant positivity for BCOR immunohistochemistry in merkel cell carcinoma - a potential diagnostic pitfall.BCOR 免疫组化在 Merkel 细胞癌中的异常阳性表达——一个潜在的诊断陷阱。
Diagn Pathol. 2024 Sep 27;19(1):130. doi: 10.1186/s13000-024-01552-8.
2
Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling.子宫腺肉瘤的鉴别诊断:通过全面癌症基因组分析鉴定 JAZF1-BCORL1 重排。
Diagn Pathol. 2023 Jan 13;18(1):5. doi: 10.1186/s13000-022-01279-4.
3
ZC3H7B-BCOR High-Grade Endometrial Stromal Sarcoma with a Mucoid Grossly Feature: A Case Report and Literature Review.具有黏液样大体特征的ZC3H7B-BCOR高级别子宫内膜间质肉瘤:一例报告及文献复习
Int J Womens Health. 2022 Dec 14;14:1701-1708. doi: 10.2147/IJWH.S390042. eCollection 2022.
4
Molecular pathogenesis and prognostication of "low-grade'' and "high-grade" endometrial stromal sarcoma.“低级别”和“高级别”子宫内膜间质肉瘤的分子发病机制和预后判断。
Genes Chromosomes Cancer. 2021 Mar;60(3):160-167. doi: 10.1002/gcc.22907. Epub 2020 Nov 10.
5
Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.靶向 RNA 表达谱分析将高级子宫内膜间质肉瘤确定为具有临床相关性的子宫肉瘤分子亚型。
Mod Pathol. 2021 May;34(5):1008-1016. doi: 10.1038/s41379-020-00705-6. Epub 2020 Oct 19.
6
Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases.免疫组织化学标志物与腺肉瘤的临床病程:七例系列病例。
Diagn Pathol. 2020 Sep 24;15(1):119. doi: 10.1186/s13000-020-01036-5.

本文引用的文献

1
Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A Morphologic and Molecular Study of 26 Cases Confirms Recurrent NCOA1-3 Rearrangement.子宫肿瘤类似于卵巢性索间质肿瘤(UTROSCT):26 例形态学和分子研究证实了 NCOA1-3 重排的复发。
Am J Surg Pathol. 2020 Jan;44(1):30-42. doi: 10.1097/PAS.0000000000001348.
2
Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation.具有可变性索分化的 GREB1 重排型子宫肉瘤的临床病理特征。
Am J Surg Pathol. 2019 Jul;43(7):928-942. doi: 10.1097/PAS.0000000000001265.
3
Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.未分化子宫肉瘤代表认识不足的高级子宫内膜间质肉瘤。
Am J Surg Pathol. 2019 May;43(5):662-669. doi: 10.1097/PAS.0000000000001215.
4
Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Distinct Entity Characterized by Recurrent NCOA2/3 Gene Fusions.具有 NCOA2/3 基因融合的复发性特征的类似于卵巢性索肿瘤的子宫肿瘤:一个独特的实体。
Am J Surg Pathol. 2019 Feb;43(2):178-186. doi: 10.1097/PAS.0000000000001153.
5
DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.DICER1 突变在苗勒管腺肉瘤中很常见,且与横纹肌肉瘤分化无关。
Mod Pathol. 2019 Feb;32(2):280-289. doi: 10.1038/s41379-018-0132-5. Epub 2018 Sep 28.
6
Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations.子宫内膜间质肉瘤及相关肿瘤:新进展与诊断要点。
Pathology. 2018 Feb;50(2):162-177. doi: 10.1016/j.pathol.2017.11.086. Epub 2017 Dec 22.
7
ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.ZC3H7B-BCOR 高级别子宫内膜间质肉瘤:一种新定义实体的 17 例报告。
Mod Pathol. 2018 Apr;31(4):674-684. doi: 10.1038/modpathol.2017.162. Epub 2017 Dec 1.
8
High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.高级别苗勒管腺肉瘤:一种具有普遍TP53通路改变和侵袭性行为的独特肿瘤的基因组及临床病理特征
Am J Surg Pathol. 2017 Nov;41(11):1513-1522. doi: 10.1097/PAS.0000000000000907.
9
BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.BCOR 是一种强有力的诊断免疫组化标志物,可用于多种遗传学上不同的高级别子宫内膜间质肉瘤,包括具有变异形态的肿瘤。
Mod Pathol. 2017 Sep;30(9):1251-1261. doi: 10.1038/modpathol.2017.42. Epub 2017 Jun 16.
10
Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcoma.肉瘤中DICER1基因测序在一例成人发病的胚胎性横纹肌肉瘤中鉴定出双等位基因体细胞DICER1突变。
Br J Cancer. 2017 Jun 6;116(12):1621-1626. doi: 10.1038/bjc.2017.147. Epub 2017 May 18.

BCOR 在 Müllerian 腺肉瘤中的表达:潜在的诊断陷阱。

BCOR Expression in Mullerian Adenosarcoma: A Potential Diagnostic Pitfall.

机构信息

Department of Pathology, University of Texas Medical Branch, Galveston, TX.

Department of Pathology, Hackensack University Medical Center, Hackensack, NJ.

出版信息

Am J Surg Pathol. 2020 Jun;44(6):765-770. doi: 10.1097/PAS.0000000000001445.

DOI:10.1097/PAS.0000000000001445
PMID:32011345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10189887/
Abstract

Adenosarcoma can mimic high-grade endometrial stromal sarcoma with ZC3H7B-BCOR fusion that may show entrapped glands and often exhibits diffuse BCOR expression. We encountered diffuse BCOR expression in rare adenosarcomas and sought to define its frequency among a larger cohort of these tumors. BCOR immunohistochemistry was performed on archival formalin-fixed paraffin-embedded tumor tissue in 13 of 14 adenosarcomas with and without stromal overgrowth arising in the uterus or ovary. The staining intensity and percentage of positive tumor nuclei in the mesenchymal component were evaluated. Eleven cases with sufficient tumoral tissue were subjected to fluorescence in situ hybridization for the detection of BCOR, BCORL1, NUTM1, ZC3H7B, and JAZF1 rearrangement. Three cases were subjected to targeted RNA sequencing. BCOR was expressed in 9 of 13 (70%) tumors, including 6 with and 3 without stromal overgrowth. Moderate to strong staining in >70% of cells was seen throughout in 1 low-grade and 6 high-grade tumors, 5 of which had stromal overgrowth. No staining was seen in 3 low-grade and 1 high-grade tumors with stromal overgrowth. One tumor demonstrating extensive sex cord-like differentiation and diffuse BCOR expression harbored JAZF1 and BCORL1 rearrangements. No BCOR or BCORL1 rearrangement was identified in the remaining tumors. BCOR expression is seen in most adenosarcomas with and without stromal overgrowth. BCORL1 rearrangement is seen in rare tumors with diffuse BCOR expression. Assessment of BCOR or BCORL1 rearrangement status is required in adenosarcomas demonstrating BCOR expression.

摘要

腺肉瘤可能模仿具有 ZC3H7B-BCOR 融合的高级子宫内膜间质肉瘤,可能显示被困腺体,并且通常表现出弥漫性 BCOR 表达。我们在罕见的腺肉瘤中发现了弥漫性 BCOR 表达,并试图在更大的肿瘤队列中确定其频率。对 14 例子宫或卵巢发生的腺肉瘤中 13 例进行了存档福尔马林固定石蜡包埋肿瘤组织的 BCOR 免疫组织化学染色,这些腺肉瘤有无间质过度生长。评估了间质成分中阳性肿瘤核的染色强度和百分比。对 11 例具有足够肿瘤组织的病例进行了荧光原位杂交检测 BCOR、BCORL1、NUTM1、ZC3H7B 和 JAZF1 重排。对 3 例进行了靶向 RNA 测序。BCOR 在 13 例中的 9 例(70%)肿瘤中表达,其中 6 例有间质过度生长,3 例无。在 1 例低级别和 6 例高级别肿瘤中,整个肿瘤中可见 70%以上细胞的中度至强染色,其中 5 例有间质过度生长。在 3 例低级别和 1 例有间质过度生长的高级别肿瘤中未见染色。一例表现出广泛的性索样分化和弥漫性 BCOR 表达的肿瘤具有 JAZF1 和 BCORL1 重排。其余肿瘤均未发现 BCOR 或 BCORL1 重排。BCOR 表达见于大多数有和无间质过度生长的腺肉瘤。在具有弥漫性 BCOR 表达的罕见肿瘤中可见 BCORL1 重排。在表现出 BCOR 表达的腺肉瘤中,需要评估 BCOR 或 BCORL1 重排状态。